Cann Group Ltd
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Cann Group Ltd (CAN) - Net Assets
Latest net assets as of June 2025: AU$-2.77 Million AUD
Based on the latest financial reports, Cann Group Ltd (CAN) has net assets worth AU$-2.77 Million AUD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$78.79 Million) and total liabilities (AU$81.56 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-2.77 Million |
| % of Total Assets | -3.52% |
| Annual Growth Rate | N/A |
| 5-Year Change | -103.02% |
| 10-Year Change | -117.64% |
| Growth Volatility | 275.32 |
Cann Group Ltd - Net Assets Trend (2015–2025)
This chart illustrates how Cann Group Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cann Group Ltd (2015–2025)
The table below shows the annual net assets of Cann Group Ltd from 2015 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-2.77 Million | -119.93% |
| 2024-06-30 | AU$13.92 Million | -76.51% |
| 2023-06-30 | AU$59.26 Million | -30.20% |
| 2022-06-30 | AU$84.90 Million | -7.59% |
| 2021-06-30 | AU$91.87 Million | +50.43% |
| 2020-06-30 | AU$61.07 Million | -20.99% |
| 2019-06-30 | AU$77.30 Million | -9.98% |
| 2018-06-30 | AU$85.87 Million | +485.76% |
| 2017-06-30 | AU$14.66 Million | -6.83% |
| 2016-12-31 | AU$15.73 Million | +831.35% |
| 2016-06-30 | AU$1.69 Million | +160.59% |
| 2015-06-30 | AU$648.33K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cann Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19007781400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$187.95 Million | % |
| Other Comprehensive Income | AU$1.09 Million | % |
| Total Equity | AU$-2.77 Million | 100.00% |
Cann Group Ltd Competitors by Market Cap
The table below lists competitors of Cann Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Western Forest Products Inc
PINK:WFSTF
|
$2.39 Million |
|
Eminence Minerals Limited
AU:EMA
|
$2.39 Million |
|
Next Biometrics Group ASA
OL:NEXT
|
$2.39 Million |
|
RYL CARIBBEAN CRU
MU:RC8
|
$2.39 Million |
|
Ho Hup Construction Company
KLSE:5169
|
$2.39 Million |
|
Artego Tg. Jiu
RO:ARTE
|
$2.39 Million |
|
Teligent Inc
PINK:TGNT
|
$2.39 Million |
|
One SA
WAR:FMG
|
$2.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cann Group Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 13,921,000 to -2,775,000, a change of -16,696,000 (-119.9%).
- Net loss of 22,345,000 reduced equity.
- Share repurchases of 2,827,000 reduced equity.
- Other comprehensive income increased equity by 598,000.
- Other factors increased equity by 7,878,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-22.34 Million | -805.23% |
| Share Repurchases | AU$2.83 Million | -101.87% |
| Other Comprehensive Income | AU$598.00K | +21.55% |
| Other Changes | AU$7.88 Million | +283.89% |
| Total Change | AU$- | -119.93% |
Book Value vs Market Value Analysis
This analysis compares Cann Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-06-30 | AU$0.01 | AU$0.01 | x |
| 2016-06-30 | AU$0.02 | AU$0.01 | x |
| 2017-06-30 | AU$0.28 | AU$0.01 | x |
| 2018-06-30 | AU$0.69 | AU$0.01 | x |
| 2019-06-30 | AU$0.55 | AU$0.01 | x |
| 2020-06-30 | AU$0.43 | AU$0.01 | x |
| 2021-06-30 | AU$0.35 | AU$0.01 | x |
| 2022-06-30 | AU$0.25 | AU$0.01 | x |
| 2023-06-30 | AU$0.16 | AU$0.01 | x |
| 2024-06-30 | AU$0.03 | AU$0.01 | x |
| 2025-06-30 | AU$-0.01 | AU$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cann Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -168.60%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-116.31%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | -644.19% | -30391.84% | 0.02x | 1.12x | AU$-4.24 Million |
| 2016 | -86.54% | -21945.53% | 0.00x | 1.11x | AU$-1.63 Million |
| 2017 | -17.66% | -30737.98% | 0.00x | 1.03x | AU$-4.05 Million |
| 2018 | -5.50% | -780.30% | 0.01x | 1.01x | AU$-13.31 Million |
| 2019 | -14.14% | -418.96% | 0.03x | 1.06x | AU$-18.66 Million |
| 2020 | -27.73% | -2616.94% | 0.01x | 1.25x | AU$-23.04 Million |
| 2021 | -27.32% | -584.74% | 0.04x | 1.11x | AU$-34.29 Million |
| 2022 | -31.17% | -412.85% | 0.05x | 1.64x | AU$-34.96 Million |
| 2023 | -57.02% | -245.26% | 0.11x | 2.18x | AU$-39.72 Million |
| 2024 | -368.09% | -333.32% | 0.17x | 6.66x | AU$-52.63 Million |
| 2025 | 0.00% | -168.60% | 0.17x | 0.00x | AU$-22.07 Million |
Industry Comparison
This section compares Cann Group Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $21,702,735
- Average return on equity (ROE) among peers: -166.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cann Group Ltd (CAN) | AU$-2.77 Million | -644.19% | N/A | $2.39 Million |
| Aft Pharmaceuticals Ltd (AFP) | $28.23 Million | -47.00% | 1.31x | $53.97 Million |
| Althea Group Holdings Ltd (AGH) | $42.70 Million | -35.24% | 0.26x | $6.03 Million |
| BOD Science Ltd (BOD) | $3.47 Million | -155.95% | 0.53x | $1.38 Million |
| BPH Global Ltd (BP8) | $-1.46 Million | 0.00% | 0.00x | $781.31K |
| ECS Botanics Holdings Ltd (ECS) | $188.48K | -116.04% | 0.13x | $2.73 Million |
| IDT Australia Ltd (IDT) | $25.01 Million | -24.32% | 0.25x | $8.48 Million |
| Invion Ltd (IVX) | $19.58 Million | -11.45% | 0.02x | $2.48 Million |
| Little Green Pharma Ltd (LGP) | $77.26 Million | -10.55% | 0.12x | $14.26 Million |
| Live Verdure Ltd (LV1) | $362.12K | -1094.69% | 2.55x | $28.27 Million |